Arrhythmias & electrophysiology

Prophylactic pulmonary vein isolation in patients with typical atrial flutter and heart failure

Heart RhythmPublished prospective, nonrandomized, controlled study

Main finding · Composite of death from any cause or hospitalization for worsening HFResult — go to the resultAdjusted hazard ratio 0.37 95% CI 0.17–0.82

Authors' conclusion

In this prospective, nonrandomized, controlled study of patients with AFL and HF, prophylactic CPVI was associated with a significantly lower rate of a composite of death from any cause or hospitalization for worsening HF than CTI ablation alone. However, randomized trial verification is required.

Study context

Population
Patients with typical atrial flutter (AFL) and heart failure (HF)
Participants
42 vs 39
Exposure
Cavotricuspid isthmus (CTI) ablation + circumferential pulmonary vein isolation (CPVI) vs CTI ablation alone
  • CTI + CPVI groupn = 42
  • CTI-alone groupn = 39reference
Outcome
Composite of:
  • Death from any cause
  • Hospitalization for worsening HF
Follow-up
Mean 40.2 ± 12.9 months
Methodological detailsconsecutively enrolled, 9 centers
  • Consecutively enrolled
  • 9 centers

Main finding

As reported in the abstract

Adjusted hazard ratio

0.37

95% CI 0.17–0.82

P = 0.014

Events by group

CTI + CPVI groupvs CTI-alone group
adjusted hazard ratio 0.37 (95% CI 0.17–0.82); P = 0.014

Observational data: associations, not effects.

Further findings

OutcomeCTI + CPVI groupCTI-alone groupAdjusted hazard ratio (95% CI)P value
Hospitalization for worsening HF · mean follow-up of 40.2 ± 12.9 months26.2%48.7%0.40 (0.17–0.94)P = 0.037

Baseline characteristics

Baseline characteristics were balanced between the 2 groups

Original publication

Prophylactic pulmonary vein isolation in patients with typical atrial flutter and heart failure. Heart Rhythm. Published 19 August 2025. doi:10.1016/j.hrthm.2025.08.022

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.